Global SYMPLICITY Registry Locations and Inclusion Criteria a,b
description
Transcript of Global SYMPLICITY Registry Locations and Inclusion Criteria a,b
![Page 1: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/1.jpg)
![Page 2: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/2.jpg)
![Page 3: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/3.jpg)
Global SYMPLICITY RegistryLocations and Inclusion Criteriaa,b
![Page 4: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/4.jpg)
SYMPLICITY RegistryMajor Adverse Events
![Page 5: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/5.jpg)
SYMPLICITY RegistryChange in Office SBP
![Page 6: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/6.jpg)
SYMPLICITY RegistryHigh Baseline BP Subset
![Page 7: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/7.jpg)
SYMPLICITY RegistryDesign Implications for Clinical Practicea,b
![Page 8: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/8.jpg)
Treatment Effectiveness in RDNResponse Assessment
![Page 9: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/9.jpg)
SYMPLICITY RegistryPredictors of RDN Response
![Page 10: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/10.jpg)
Number and Types of Comorbidities
RDN Response
![Page 11: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/11.jpg)
Biomarkers of RDN Effectiveness Current and Future Directions
![Page 12: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/12.jpg)
SYMPLICITY HTN-3Resultsa,b
![Page 13: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/13.jpg)
SYMPLICITY HTN-3Subgroup Analyses
![Page 14: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/14.jpg)
SYMPLICITY HTN-3Medication Changesa
![Page 15: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/15.jpg)
SYMPLICITY HTN-3 Medication Types
![Page 16: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/16.jpg)
SYMPLICITY HTN-3Medication Types (cont)a
![Page 17: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/17.jpg)
SYMPLICITY HTN-3African-American Population
![Page 18: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/18.jpg)
SYMPLICITY HTN-3African-American Population
(cont)a
![Page 19: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/19.jpg)
SYMPLICITY HTN-3African-American Population
(cont)a
![Page 20: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/20.jpg)
SYMPLICITY HTN-3 Procedural Effects – No. of Ablations
![Page 21: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/21.jpg)
SYMPLICITY HTN-3Procedural Effects – Circumferentiality
![Page 22: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/22.jpg)
Other RDN Procedural Factors
![Page 23: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/23.jpg)
ConclusionsRDN Moving Forward
![Page 24: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/24.jpg)
Abbreviations
![Page 25: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/25.jpg)
References
![Page 26: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/26.jpg)
References (cont)
![Page 27: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/27.jpg)
References (cont)
![Page 28: Global SYMPLICITY Registry Locations and Inclusion Criteria a,b](https://reader035.fdocuments.net/reader035/viewer/2022062408/56813b47550346895da42c6d/html5/thumbnails/28.jpg)
References (cont)